Pfizer to acquire obesity-drug maker Metsera for $4.9 bn
US pharmaceutical giant Pfizer will acquire Metsera, a maker of drugs for obesity and heart disease, for $4.9 billion, the companies said Monday. With the purchase, Pfizer aims to expand its portfolio by entering the huge and growing market for
by APF
Read More
